MRSi 2022: 20 Years Of Innovation In Reproductive Medicine
David Stern, MBA
David Stern has over 30 years of women’s health experience and has devoted the majority of his career to the fertility industry. He has held executive leadership positions and built successful teams while launching numerous products in pharmaceutical and biotech markets world-wide. Currently, David serves as the CEO of Boston IVF, one the largest IVF center networks in the United States, and part of IVIRMA Global, the largest fertility group in the world in 2024. David was CEO of Symbiomix Therapeutics a venture backed biotech company and led the transition of the company from development to commercial launch in the US, prior to its acquisition by Lupin. He serves on the board of several women's health focused companies helping them with development, KOL management and commercialization strategy. David was the SVP and Head of the Global Business Franchise for Fertility at Merck Serono, responsible for the strategic development and growth of the portfolio world-wide. Prior to his global role, he was responsible for the US commercial operations for Endocrinology. He has an MBA in International Marketing and Management from the F.W. Olin School of Business at Babson College and holds a Bachelors’ degree in Biology from Brandeis University.
Sessions
The Impact Of Private Equity In Fertility - Sponsored By Univfy
Thursday, June 9, 2022
3:30pm - 4:15pm CST